| Tag | Content |
|---|
EnhancerAtlas ID | HS091-17680 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr16:67547250-67549280 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr16:67547473-67547488 | GAGATCATGAGGTCA | + | 6.04 | | Nr2f6(var.2) | MA0728.1 | chr16:67547481-67547496 | GAGGTCAGGAGTTCA | + | 6.22 | | Stat6 | MA0520.1 | chr16:67548487-67548502 | GACTTCCTGGGAACT | + | 6.17 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10318 | chr16:67547568-67549035 | CD19_Primary | | SE_59567 | chr16:67540214-67566120 | Ly3 | | SE_63110 | chr16:67522480-67566742 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr16 | 67548262 | 67548661 | | chr16 | 67548400 | 67549081 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I067514 | chr16 | 67548104 | 67553600 |
|
Enhancer Sequence | CGGGTGTGTT GGAGCACGCC TTTAGTCCCA GCTACTTGGG AGGCTGAGAC GGGAGAATCA 60
CCTGAACCCA GGAGGTGGAG GTTGCAGTGA GCCAAGATCG CCCTACTGCA GTCCAGCCTG 120
GCGACAGAGC GAGACTCCAT CTCAAAAAAA AAAAAAAAAG GCTGAGTATG GTAGCGCGGT 180
GTCTCAAGCC TGTAATCCCA GCACTTAGGT AGGCTGAGGC GGGGAGATCA TGAGGTCAGG 240
AGTTCAAGAC CAGCCCGACC AACATGGTGA AATACTGTCT CTACTAAAAA TACAAAAATT 300
AGCTGGGTAT TGTGGCACAC GCTTGTAATC TCAGCTACTC AGGAGGAGTA GCCTCATTTG 360
AACCCAAGAG GCGGAGCTTG CAGTGAGCCG AGATTGTGCC ACTGCACTCC AGCCTGGGTG 420
ACAGAGCAAG ACTCCGGCTC AAAAAAAAAA AAAAGAGAGT GAAAAGACAA GACAATCCAC 480
AGGATGGGAA AAAATATTTG CAAATCAAAC AACTCAGTGC AAAAGTGGGT AAAGAGCCAA 540
GTGTGGTAGT ACACACCTGT AGTCCTAGCT ACTTGGGAGG CTGAGGTGGG AGGATTGCTT 600
GAGCCCAGGA GTTTGAGACC AGCCTGGGCA ATATAGCAAG ACCCCATTTC TACAAAAAAA 660
AACTGTGTAA AATAAATATT TATCCAAATA ATATACTCAA ATGGGCTGGG CACTGTGGCT 720
CACACCTGTA ATCCCAGCAC TTTGCAGGGG CTGAAGCAGG TGGAGCTCTT GAGCCTCAGA 780
ATGGGAGATG AGCCTAGGCA ACATAGCGAG ACCATGTCTT ACAAAAAAAT ACAAAAATTA 840
GCCAGGTGTG GTGGTACATG CCTGTGATCC CAGCTACTTT GGAGGCTAAG ATGGGAGGAT 900
TGCTTGAGTC CAAGAGGTTG AGGCTGCAGT GAGCCATGAT CATGTCACTG CACTGCAGCC 960
TGAGTGACAG AGCAAGACCC TGTCTCAAAA AAAAAAATCA TTAAAATTAA AAAATAAAAT 1020
TAGCCAGGTA TGGTGGCACG AGCCTGTGGT CCTAGCTACT TGGAAGGCTG AGGCGGGAGG 1080
ATCGCTTGAG CTCAGGAGTT GGAGGTTACA GTGAACTGTG ATTGCACCAT TGCACACCAG 1140
ACCAAGACGC TGACTCAAAA AAAAAATTGT TTTTAATTGA AAGACAGTAA ATGCACGCCC 1200
CCTTGTGGGT GCATGTTTAC GCTTGCTCTC CTTTTGGGAC TTCCTGGGAA CTTCTCACTT 1260
GGTCTTCTCA GTTCACGGGG GTTATAGCCC TACAGCTCTG TTCTTGCTCC GATCTATTGA 1320
TTAGTTCCTT TCTCAGGAAA CCAACCATCA GGCCTCCCAG GTAGTATCAA GGAACTGAAA 1380
CTTTACAGAT CACTGCATCT GGACAATATG TTACCAGACC CCATACCCAT CATAACTGCC 1440
TAATCATGCT GGGTGCAGTG GCTCACACCT GTAATCCTAG CACTTTGGGA GACTGAGGCA 1500
GGCGGATCAC CTGAGGTCAG GAGTTTGAGA CCAGCCTGGC CAACATGGCA AAACCCCATC 1560
TCTCCTAAAA GTACAAAAAT TAGCCAGGCA TGGTGGCATG CCTGTAATCC CAGCTACTTG 1620
AGAGGCTGAG GCACAAGAAT CACTTGAACC CAGGAGGCAG AGGTTTCAGT GAGCCAAGAT 1680
CGCGCCACTG CACTGCAGCC TGGGTGACAG AGTAAGAATG TGTCTCTAAA TAAATAAATA 1740
AATAACTGCC TAACCAGCCA CCTGCTTCCT ATTGACCAAC TCCTCTTCCT TGCCCTTCCC 1800
TAATTCCTGT TTTCCCATAC AAGATCACAT TTCTAGCCTG CTATATAAAC CCTTAAAATC 1860
TTTTTTTTTT TTTTGAGACA GAGTTTCGCT CTTGTTGCCC AGGCTACAGT GCAGTGGCAT 1920
GATCTTGGCT CACTGCAACC TCTGCTTCCC AGGTTCAGGC AATTCTCCCA CCTCAGCCTC 1980
CTGAGTAGCT GGGATTACAG GCACCTGCCA CCATGTCTGG CTAATTTTTT 2030
|
